Total assets · 2011–2025
Biomarin Pharmaceutical total assets
$7.6B+8.7% · FY2025
Biomarin Pharmaceutical (BMRN) reported $7.6B in total assets for fiscal 2025, +8.7% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $7.6B | +8.7% | Open → |
| FY20242024-12-31 | $7.0B | +2.2% | Open → |
| FY20232023-12-31 | $6.8B | +7.3% | Open → |
| FY20222022-12-31 | $6.4B | +6.2% | Open → |
| FY20212021-12-31 | $6.0B | +2.7% | Open → |
| FY20202020-12-31 | $5.8B | +24.7% | Open → |
| FY20192019-12-31 | $4.7B | +5.9% | Open → |
| FY20182018-12-31 | $4.4B | −4.4% | Open → |
| FY20172017-12-31 | $4.6B | +15.1% | Open → |
| FY20162016-12-31 | $4.0B | +7.9% | Open → |
| FY20152015-12-31 | $3.7B | +50.7% | Open → |
| FY20142014-12-31 | $2.5B | +10.3% | Open → |
| FY20132013-12-31 | $2.2B | +43.1% | Open → |
| FY20122012-12-31 | $1.6B | +20.1% | Open → |
| FY20112011-12-31 | $1.3B | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +13.4%
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Biomarin Pharmaceutical total assets |url=https://companiesranked.com/en/company/biomarin-pharmaceutical/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Biomarin Pharmaceutical total assets. CompaniesRanked. https://companiesranked.com/en/company/biomarin-pharmaceutical/total-assetsBibTeX
@misc{companiesranked-en-company-biomarin-pharmaceutical-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Biomarin Pharmaceutical total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/biomarin-pharmaceutical/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001048477-26-000016 · August 6, 2026
{{cite web |title=Biomarin Pharmaceutical total assets — 10-Q (0001048477-26-000016) |url=https://www.sec.gov/Archives/edgar/data/1048477/000104847726000016/bmrn-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.